Rosetta Genomics Ltd

NEW
OTCPK:ROSGQ (Israel)  
$ 0.00010 -0.000099 (-99%) 10:08 PM EST
At Loss
Volume:
0
Avg Vol (2M):
0
Trade In:

Business Description

Description
Rosetta Genomics Ltd is an Israel based genomic diagnostics company operating globally. It is focused on research and development on diagnostics and therapeutics in the field of microRNAs. The firm markets and sells four diagnostic tests based on its microRNA technologies namely, RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer, mi-LUNG, mi-KIDNEY which is a microRNA-based kidney tumor classification test for pathology samples and RosettaGx Reveal which is a microRNA-based assay for the diagnosis of indeterminate thyroid fine-needle aspirate samples. Its revenues include Clinical testing revenues and Licensing revenues, of which Clinical testing revenue is maximum. The group generates its revenues mainly from diagnosing patient tissue.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
14-Day RSI
10.44

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin %
-115.52
OCF Margin %
-113.94

GF Value Rank

Name Current Vs Industry Vs History

GF Valueâ„¢

Rosetta Genomics Ltd Filings

Filing Date Document Date Form
No Filing Data

Rosetta Genomics Ltd Stock Events

Financials Calendars
Event Date Price ($)
0.083333:1 Stock Split 2017-03-17 4.80 (-12.68%)
0.066667:1 Stock Split 2012-05-15 25.20 (-15.61%)
0.25:1 Stock Split 2011-07-07 194.40 (+0.00%)
0.251117:1 Stock Split 2006-10-04 --
Show
Entries

Guru Commentaries on OTCPK:ROSGQ

No articles.

Press Release

Subject Date
No Press Release

Articles on Rosetta Genomics Ltd

No articles.

Headlines

See More
  • 1
No news.
  • 1